Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study

Sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer: A phase I dose-escalation study

(2010) Martin Reck et al.   LUNG CANCER

Sunitinib Inhibits Tumor Growth and Synergizes with Cisplatin in Orthotopic Models of Cisplatin-Sensitive and Cisplatin-Resistant Human Testicular Germ Cell Tumors

(2009) W. Castillo-Avila et al.   CLINICAL CANCER RESEARCH

Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors

(2009) Darren R. Feldman et al.   INVESTIGATIONAL NEW DRUGS

Microsatellite Instability, Mismatch Repair Deficiency, andBRAFMutation in Treatment-Resistant Germ Cell Tumors

(2009) Friedemann Honecker et al.   JOURNAL OF CLINICAL ONCOLOGY

Targeted therapies for patients with germ cell tumors

(2008) Martin H Fenner et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Pharmacotherapy of relapsed metastatic testicular cancer

(2008) C Kollmannsberger et al.   EXPERT OPINION ON PHARMACOTHERAPY

Comparative Proteome, Transcriptome, and Genome Analysis of a Gonadal and an Extragonadal Germ Cell Tumor Cell Line

(2008) Stephanie Glaesener et al.   JOURNAL OF PROTEOME RESEARCH